People · Operator
Named in public records as an officer, director or promoter · active 2024–2024 · Medical Devices
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| EarliTec Diagnostics, Inc. | — | Medical Devices | Series B | $27.0M | $159.8M | 2024 |
James V. Adox at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James V. Adox on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Thomas V Ressemann | 1 | 3 |
| Jim V. Grien | 1 | 1 |
| William V. Marks | 1 | 1 |
| Kurt V. Jacobus | 1 | 1 |
| Jack Griffis | 1 | 1 |
| Jacobus Kurt | 1 | 1 |
| Thomas Ressemann | 1 | 1 |
| Jim Grien | 1 | 1 |
| Jones Warren | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.